TMCnet - World's Largest Communications and Technology Community



Research and Markets: Global Endometriosis Market 2014-2018 with Abbvie Inc., AstraZeneca plc, Bayer AG & Pfizer Inc. Dominating
[July 17, 2014]

Research and Markets: Global Endometriosis Market 2014-2018 with Abbvie Inc., AstraZeneca plc, Bayer AG & Pfizer Inc. Dominating

DUBLIN --(Business Wire)--

Research and Markets ( has announced the addition of the "Global Endometriosis Market 2014-2018" report to their offering.

This report covers the present scenario and the growth prospects of the Global Endometriosis market for the period 2013-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of endometriosis that are available in the market.

The launch of high-cost GnRH antagonist therapies such as AbbVie's Elagolix (which is in phase III trial) is expected during the forecast period. Currently, the market is being served by low-cost alternatives such as combined OCPs, NSAIDs, and progestins. Patients tend to choose low-cost alternatives, which will be a challenge to the high-cost GnRH Antagonist market.

According to the report, the Global Endometriosis market is driven by a large amount of unmet need due to lack of diagnostics and lack f approved treatment options for the disease. Currently, the diagnosis is mainly through non-invasive methods where standard diagnostic procedures are not available. Thus, development of proper diagnostic tools for the early detection of the disease will increase the number of patients treated. A lack of approved drugs for the treatment of endometriosis creates a lucrative space for companies to develop new therapy options to enter the market.

Further, the report states that one of the main challenges is patent expiries of endometriosis drugs which leads to loss of exclusive rights of branded products followed by the introduction of low-priced generics into the market. This poses a potential threat to the established companies that spend a huge amount on R&D.

The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Key Vendors

  • Abbvie Inc.
  • AstraZeneca plc
  • Bayer AG
  • Pfizer Inc.

Other Prominent Vendors

  • Astellas Pharma Inc.
  • Abbvie Inc.
  • Repros Therapeutics Inc.
  • Sanofi SA
  • Takeda Pharmaceuticals Co. Ltd.

Key Topics Covered:

  1. Executive Summary
  2. List of Abbreviations
  3. Scope of the Report
  4. Market Research Methodology
  5. Introduction
  6. Market Landscape
  7. Rate of Incidence and Prevalence
  8. Market Segmentation by Type of Therapy
  9. Market Segmentation by Route of Administration and Type of Dosage Form
  10. Pipeline Portfolio
  11. Geographical Segmentation
  12. Buying Criteria
  13. Market Growth Drivers
  14. Drivers and their Impact
  15. Market Challenges
  16. Impact of Drivers and Challenges
  17. Market Trends
  18. Trends and their Impact
  19. Vendor Landscape
  20. Key Vendor Analysis

For more information visit

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy